On August 23, US President Donald Trump announced that US Food and Drug Administration (FDA) has approved plasma therapy usage in the treatment of Covid-19 patients.
Due to Operation Warp Speed, the president said the approval has come at lightning speed, and also a vaccine is about to be released for the novel virus soon.
To achieve the plasma therapy approval in a short span, bureaucratic barriers and unnecessary delays have been addressed while maintaining the sanctity of processes.
President Trump also said that nearly USD 48 million had been invested in conducting the research studies required to test the efficiency of the plasma treatment, which is also said to reduce mortality by 35 percent.
With nearly one lakh of Americans enrolled in receiving the plasma treatment, the FDA has given the green signal on this treatment due to its high efficiency and safety.
President Donald Trump has made a broad appeal to all Americans who have recovered from coronavirus to donate plasma. As per the President, the US has the lowest case fatality rate amongst all the world countries.
US FDA also issued a press statement which offers an Emergency Use Authorization (EUA) for treating Covid-19 in patients.
More US Articles:
- Kamala Harris, an Indian-American Senator, to run 2020 elections with Joe Biden
- President Donald Trump allows relaxation on H-1B visa ban
- H-1B Visa Freeze: Will That Help Americans, More in The Offing?
- Planning an international flight from India? Know the new travel rules